Walgreens is tracked by 25 Wall Street analysts. Together, they’ve rated the company a 2.0 on a scale of 1.0 for “strong buy” to 5.0 for “sell.” In comparison, Rite Aid, which is covered by eight analysts, has been given a rating of 2.6, reflecting its not-so-strong fundamentals.
About 76.0% of Walgreens analysts are recommending a “buy” for the stock, and 24.0% are recommending a “hold.” Only 38.0% are recommending a “buy” for Rite Aid, while the remaining are recommending a “hold.” None of the analysts have recommended a “sell” for either company.
If you’re seeking to add exposure to WBA or RAD, you could consider the First Trust Consumer Staples AlphaDEX ETF (FXG), which invests 5.1% of its combined portfolio in the two companies.
View more information: https://marketrealist.com/2017/03/the-wba-rad-merger-and-the-43-fall-in-rite-aid-stock/